Synapse - Genitourinary Oncology Service

Results (5695)

Testicular cancer, version 2.2020

Guidelines

Gilligan, T.; Lin, D. W.; Aggarwal, R.; Chism, D.; Cost, N.; Derweesh, I. H.; Emamekhoo, H.; Feldman, D. R.; Geynisman, D. M.; Hancock, S. L.; more...
Journal of the National Comprehensive Cancer Network (2019)

Fulltext@MSK | Save

Phase I study of DSTP3086S, an antibody-drug conjugate targeting six-transmembrane epithelial antigen of prostate 1, in metastatic castration-resistant prostate cancer

Journal Article

Danila, D. C.; Szmulewitz, R. Z.; Vaishampayan, U.; Higano, C. S.; Baron, A. D.; Gilbert, H. N.; Brunstein, F.; Milojic-Blair, M.; Wang, B.; Kabbarah, O.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection

Journal Article

Shah, N. J.; Al-Shbool, G.; Blackburn, M.; Cook, M.; Belouali, A.; Liu, S. V.; Madhavan, S.; He, A. R.; Atkins, M. B.; Gibney, G. T.; more...
Journal for ImmunoTherapy of Cancer (2019)

Fulltext@MSK | Save

Impact of FDG PET imaging for expanding patient eligibility and measuring treatment response in a genome-driven basket trial of the Pan-HER kinase inhibitor, neratinib

Journal Article

Ulaner, G. A.; Saura, C.; Piha-Paul, S. A.; Mayer, I.; Quinn, D.; Jhaveri, K.; Stone, B.; Shahin, S.; Mann, G.; Dujka, M.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

Analysis of tumor genomic pathway alterations using broad-panel next-generation sequencing in surgically resected lung adenocarcinoma

Journal Article

Zhou, J.; Sanchez-Vega, F.; Caso, R.; Tan, K. S.; Brandt, W. S.; Jones, G. D.; Yan, S.; Adusumilli, P. S.; Bott, M.; Huang, J.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

First-in-human phase I study of a dual mTOR kinase and DNA-PK inhibitor (CC-115) in advanced malignancy

Journal Article

Munster, P.; Mita, M.; Mahipal, A.; Nemunaitis, J.; Massard, C.; Mikkelsen, T.; Cruz, C.; Paz-Ares, L.; Hidalgo, M.; Rathkopf, D.; more...
Cancer Management and Research (2019)

Fulltext@MSK | Save

Integrated germline and somatic analysis identifies actionable cancer predisposing germline mutations in 9,734 patients with advanced cancers

Meeting Abstract

Jayakumaran, G.; Mandelker, D.; Birsoy, O.; Jairam, S.; Li, Y.; Yang, C.; Somar, J.; Rai, V.; Syed, A.; Benayed, R.; more...
Journal of Molecular Diagnostics (2019)

Fulltext@MSK | Save

Sitravatinib in combination with nivolumab demonstrates clinical activity in platinum-experienced patients with urothelial carcinoma (UC) who progressed on prior immune checkpoint inhibitor (CPI)

Meeting Abstract

Msaouel, P.; Siefker-Radtke, A.; Sweis, R.; Mortazavi, A.; Vogelzang, N.; Vaishampayan, U.; Bradley, T.; Bupathi, M.; Nordquist, L.; Shaffer, D.; more...
Journal for ImmunoTherapy of Cancer (2019)

Fulltext@MSK | Save

A multicenter, open-label, exploratory platform study to evaluate biomarkers and immunotherapy combinations for the treatment of patients with metastatic castration-resistant prostate cancer (PORTER)

Meeting Abstract

Nissola, L.; Autio, K.; Bhardwaj, N.; Galsky, M.; Wentzel, K.; Lucey, V.; Selinsky, C.; Perry, C.; Cabanski, C.; Bitton, A.; more...
Journal for ImmunoTherapy of Cancer (2019)

Fulltext@MSK | Save

Phase 2 study of lenvatinib (LEN) plus pembrolizumab (PEMBRO) for disease progression after PD-1/PD-L1 immune checkpoint inhibitor (ICI) in metastatic clear cell renal cell carcinoma (mccRCC): Results of an interim analysis

Meeting Abstract

Lee, C. H.; Shah, A. Y.; Makker, V.; Taylor, M.; Shaffer, D.; Hseih, J. J.; Cohn, A. L.; Di Simone, C.; Marin, A. P.; Rasco, D.; more...
Asia-Pacific Journal of Clinical Oncology (2019)

Fulltext@MSK | Save